Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT01151605
NA

The Suppression of Toll Like Receptors by Insulin

Sponsor: University at Buffalo

View on ClinicalTrials.gov

Summary

This study will help us understand the possible beneficial effects of insulin in inflammation. Inflamamtion is considered to be the cause of atherosclerosis and heart disease.

Key Details

Gender

All

Age Range

20 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

42

Start Date

2008-09

Completion Date

2013-12

Last Updated

2026-09-11

Healthy Volunteers

Yes

Interventions

DRUG

insulin infusion

insulin to be infused at 3.5 units/hour along with Dextrose 12.5% at a rate to achieve blood glucose levels between 80-120mg/dl

DRUG

Dextrose infusion

Dextrose 12.5% will be infused at a rate to maintain blood glucose level 80-120mg/dl

DRUG

Saline Infusion

Saline will be infused at 100ml/hr

Locations (1)

Millard Fillmore Gates Hospital

Buffalo, New York, United States